BioCentury
ARTICLE | Company News

Presage Biosciences, Takeda deal

April 9, 2012 7:00 AM UTC

Presage partnered with Takeda's Millennium Pharmaceuticals Inc. subsidiary to use Presage's technology for preclinical identification of effective drug combinations in solid tumors. Presage will receive upfront fees and research funding, and is eligible for milestones related to identification of successful drug combinations. ...